Pharma penny stock under Rs 50 in focus as company inaugurates its state-of-the-art R&D center in Hyderabad Pharma penny stock under Rs 50 in focus as company inaugurates its state-of-the-art R&D center in Hyderabad From Rs 34.51 per share (52-week low) to Rs 56.15 per share, the stock is up by 55.3 per cent. DSIJ Intelligence-1 / Wednesday, June 18, 2025 0 561 Article rating: 4.3 From Rs 34.51 per share (52-week low) to Rs 56.15 per share, the stock is up by 55.3 per cent. Read more
Pharma Penny Stock Under Rs 50: Company Is Establishing A State-Of-The-Art R&D Center In Hyderabad To Enhance Its Capabilities Pharma Penny Stock Under Rs 50: Company Is Establishing A State-Of-The-Art R&D Center In Hyderabad To Enhance Its Capabilities From Rs 43.42 per share (52-week low) to Rs 45.49 per share, the stock is up by 5 per cent. DSIJ Intelligence-1 / Wednesday, February 5, 2025 0 644 Article rating: 3.3 From Rs 43.42 per share (52-week low) to Rs 45.49 per share, the stock is up by 5 per cent. Read more
Penny Stock Under Rs 50: Company acquired 100% stake in Cibachem General Trading L.L.C & Premises taken on rent for setting up new R&D centre in Dehradun Penny Stock Under Rs 50: Company acquired 100% stake in Cibachem General Trading L.L.C & Premises taken on rent for setting up new R&D centre in Dehradun The stock gave multibagger returns of 658 per cent from its 52-week low of Rs 5.82 per share. DSIJ Intelligence-1 / Friday, January 17, 2025 0 620 Article rating: 4.0 The stock gave multibagger returns of 658 per cent from its 52-week low of Rs 5.82 per share. Read more